Implantable therapy systems and methods

Surgery – Controlled release therapeutic device or system

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

604 93, 604164, 604265, 424424, A61K 922

Patent

active

054877393

ABSTRACT:
Implantable therapy systems are disclosed for the local and controlled delivery of a biologically active factor to the brain, spinal cord and other target regions of a subject suffering from a debilitating condition. The method of the invention involves surgically exposing an insertion site, generally located above a predetermined treatment site (12), in a patient. A cannula (20), having an obturator (30) or dilator (104) positioned therein, is inserted at the insertion site, defining a pathway to the treatment site. In some instances, the cannula can be inserted along the path of a guidewire (102) previously positioned at the treatment site. The cannula (20) is preferably a low friction polymeric material such as polytetrafluoroethylene. The cannula (20) generally has an open proximal end for receiving the obturator (30) or dilator (104), and an open distal end, preferably a tapered end, for delivery of neurologically active factors to the treatment site (12). The obturator (30) is then removed from the cannula (20), and a biocompatible tethered vehicle (40) containing a biologically active material is inserted into the cannula along the passageway. A pusher can be inserted within the cannula, behind the vehicle (40), to position the proximal end of the vehicle at the distal end of the cannula (20b). Once the vehicle (40) is positioned near the distal end of the cannula (20), the cannula is removed from the passageway, followed by the pusher, leaving the vehicle (40) positioned at the treatment site (12).

REFERENCES:
patent: 3093831 (1963-06-01), Jordan et al.
patent: 3583387 (1971-06-01), Garner
patent: 3640269 (1972-02-01), Delgado
patent: 3911911 (1975-10-01), Scommegna
patent: 4241187 (1980-12-01), White
patent: 4298002 (1981-11-01), Ronel et al.
patent: 4309776 (1982-01-01), Berguer
patent: 4352883 (1982-11-01), Lim
patent: 4378016 (1983-03-01), Loeb
patent: 4391909 (1982-07-01), Lim
patent: 4402694 (1983-09-01), Ash et al.
patent: 4451253 (1984-05-01), Harman
patent: 4479796 (1984-10-01), Kallok
patent: 4578057 (1986-03-01), Sussman
patent: 4619644 (1986-10-01), Scott
patent: 4686098 (1987-08-01), Kopchick et al.
patent: 4767400 (1988-08-01), Miller et al.
patent: 4850975 (1989-07-01), Furukawa
patent: 4892538 (1990-01-01), Aebisher et al.
patent: 4902295 (1990-02-01), Waltham et al.
patent: 4931056 (1990-06-01), Ghajar et al.
patent: 4941874 (1990-07-01), Sandow et al.
patent: 4960415 (1990-10-01), Reinmuller
patent: 4973304 (1990-11-01), Graham et al.
patent: 4976670 (1990-12-01), Franetzki et al.
patent: 4994027 (1991-02-01), Farrell
patent: 5004457 (1991-04-01), Wyatt et al.
patent: 5106627 (1992-04-01), Aebisher et al.
patent: 5125888 (1992-06-01), Howard et al.
patent: 5139486 (1992-08-01), Moss
patent: 5158544 (1992-10-01), Weinstein
patent: 5292515 (1994-03-01), Moro et al.
Tresco et al. (1992) ASAIO Journal 38:17-23.
Aebisher et al. (1991) Science 252:133.
Winn et al. (1991) Experimental Neurology 113:322-329.
Aebisher et al. (1991) Brian Research 560:43-49.
Aebisher et al. (1991) Experimental Neurology 111:269-275.
Aebisher et al. (1991) J. Biomech. Engineering 113:178-183.
Aebisher et al. (1991) Biomaterials 12:50-56.
Jaeger et al. (1991) Brian Research 551:163-170.
Hoffman et al. (1990) Experimental Neurology 110:39-44.
Winn et al. (1989) Experimental Neurology 105:244-250.
Winn et al. (1989) J. Biomed. Mater. Res. 23:31-44.
Aebisher et al. (1988) Brian Research 448:364-368.
Jaeger et al. (1990) Progress In Brain Research 82:41-46.
Bjorklund et al. (1982) Nature 298:652-654.
Brundin et al. (1985) Experimental Brain Research 60:204-208.
Calne et al. (1969) The Lancet Nov. 8, pp. 973-976.
Calne et al. (1974) British Medical Journal Nov. 23, pp. 442-444.
M. A. Dichter (1983) Principal of Internal Medicine pp. 2018, 2119-2132.
Freed et al. (1981) Nature 292:351.
Hefti et al. (1985) Brain Research 348:283-288.
Perlow et al. (1979) Science 204:643-647.
Stenaas and Stenaas, (1978) ACTA Neuropath. 41:145-155.
Sun et al. (1977) Diabetes 26:1136-1139.
Sagen et al., "Adrenal Medullary Transplants Increase Spinal Cord Cerebrospinal Fluid Catecholamine Levels and Reduce Pain Sensitivity," Journal of Neurochemistry, vol. 56, No. 2, pp. 623-627 (1991).
Sagen et al., "Increased Levels of Met-enkephalin-like Immunoreactivity in the Spinal Cord CSF of Rats with Adrenal Medullary Transplants," Brain Research, 502, pp. 1-10 (1989).
Sagen et al., "Adrenal Medullary Tissue Transplants in the Rat Spinal Cord Reduce Pain Sensitivity," Brain Research, 384, pp. 189-194 (1986).
Sagen et al., "Analgesia Induced by Isolated Bovine Chromaffin Cells Implanted in Rat Spinal Cord," Neurobiology, vol. 83, pp. 7522-7526 (1986).
Sagen et al., "Fine Structure of Adrenal Medullary Grafts in the Pain Modulatory Regions of the Rat Periaqueductal Gray," Experimental Brain Research, pp. 380-390 (1987).
Sagen et al., "Monoaminergic Neural Transplants Prevent Learned Helplessness in a Rat Depression Model," Society of Biological Psychiatry, vol. 28, pp. 1037-1048 (1990).
Sagen et al., "Proloned Analgesia by Enkephalinase Inhibition in Rats With Spinal Cord Adrenal Medullary Transplants," European Journal of Pharmacology, vol. 179, pp. 427-433 (1990).
Pezzoli et al., "Non-chromaffin Tissue Plus Nerve Growth Factor Reduces Experimental Parkinsonism in Aged Rats," Brain Research, vol. 459, pp. 398-403 (1988).
Tze et al., "Xenotransplantation of Rat Pancreatic Endocrine Cells in Spontaneous and Streptozotocin-induced Diabetic Monkeys," Translation Proceedings, vol. 21, No. 1, pp. 2736-2738 (1989).
Stark et al., "Enhanced Antinociception by Adenosinergic Agonists in Rats With Adrenal Medullary Transplants in the Spinal Subarachnoid Space," Society of Neuroscience Abstracts, vol. 17, 99.4 (1991) **Abstract Only**.
Hama et al., "Adrenal Medullary Transplants Reduce Pain in Rats With Experimental Painful Peripheral Neuropathy," Society for Neuroscience Abstracts, vol. 17, 99.6 (1991) **Abstract Only**.
Sagen et al., "Pain Recuction by Adrenal Medullary Transplants in the Spinal Subarachnoid Space of Terminal Cancer Patients," Society for Neuroscience Abstracts, vol. 17, 99.1 (1991) **Abstract Only**.
Wang et al., "Pain Reduction by Transplants of Polymer Encapsulated Bovine Chromaffin Cells in the Rat Spinal Subarachnoid Space," Society for Neuroscience Abstracts, vol. 17, 99.5 (1991).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Implantable therapy systems and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Implantable therapy systems and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Implantable therapy systems and methods will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-154818

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.